Volume 129, Issue 4, Pages (October 2005)

Slides:



Advertisements
Similar presentations
Volume 133, Issue 1, Pages (July 2007)
Advertisements

Volume 131, Issue 4, Pages (October 2006)
Volume 1, Issue 2, Pages (March 2002)
Volume 128, Issue 1, Pages (January 2005)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 132, Issue 5, Pages (May 2007)
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 11, Issue 6, Pages (June 2003)
Volume 118, Issue 4, Pages (April 2000)
Volume 133, Issue 5, Pages (November 2007)
Volume 133, Issue 1, Pages (July 2007)
Volume 137, Issue 4, Pages e3 (October 2009)
Volume 123, Issue 5, Pages (November 2002)
Volume 7, Issue 5, Pages (May 2001)
Volume 136, Issue 5, Pages (May 2009)
PTF1α/p48 and cell proliferation
by Wu-Guo Deng, Ying Zhu, and Kenneth K. Wu
Volume 129, Issue 5, Pages (November 2005)
Volume 126, Issue 7, Pages (June 2004)
Volume 129, Issue 1, Pages (July 2005)
Volume 142, Issue 7, Pages e6 (June 2012)
Tom Misteli, David L Spector  Molecular Cell 
Volume 142, Issue 3, Pages (March 2012)
Volume 138, Issue 2, Pages (February 2010)
Eija Siintola, Meral Topcu, Nina Aula, Hannes Lohi, Berge A
Volume 128, Issue 7, Pages (June 2005)
Volume 131, Issue 4, Pages (October 2006)
Volume 138, Issue 1, Pages e3 (January 2010)
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Volume 9, Issue 2, Pages (January 1999)
Volume 16, Issue 6, Pages (December 2004)
HES1 is a novel interactor of the Fanconi anemia core complex
Volume 127, Issue 4, Pages (October 2004)
Volume 62, Issue 4, Pages (October 2002)
Volume 10, Issue 3, Pages (September 2006)
17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production  Naoko Kanda, Shinichi.
Volume 142, Issue 3, Pages e2 (March 2012)
Oncogenic ras induces gastrin gene expression in colon cancer
Volume 128, Issue 7, Pages (June 2005)
Volume 25, Issue 9, Pages (September 2017)
Eun-Joo Kim, Jeong-Hoon Kho, Moo-Rim Kang, Soo-Jong Um  Molecular Cell 
Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing  Akihiko Miyanaga, MD, PhD, Mari Masuda, PhD, Koji.
Volume 86, Issue 3, Pages (August 1996)
Volume 135, Issue 3, Pages e3 (September 2008)
Volume 22, Issue 2, Pages (February 2014)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 138, Issue 1, Pages e5 (January 2010)
Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53  Yanping Zhang, Yue Xiong 
A Novel Role of Transforming Growth Factor β1 in Transcriptional Repression of Human Cholesterol 7α-Hydroxylase Gene  Tiangang Li, John Y.L. Chiang  Gastroenterology 
Volume 17, Issue 8, Pages (November 2016)
Livio Pellizzoni, Naoyuki Kataoka, Bernard Charroux, Gideon Dreyfuss 
Regulation of Wnt Signaling by the Nuclear Pore Complex
Volume 2, Issue 1, Pages (July 1998)
Volume 6, Issue 3, Pages (September 2000)
Volume 127, Issue 4, Pages (October 2004)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Barbara Marinari, Costanza Ballaro, Maranke I
A Dynamic Molecular Link between the Telomere Length Regulator TRF1 and the Chromosome End Protector TRF2  Benjamin R. Houghtaling, Leanora Cuttonaro,
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation  Dimitrios Iliopoulos, Heather A. Hirsch,
SUMO-1 Modification Represses Sp3 Transcriptional Activation and Modulates Its Subnuclear Localization  Sarah Ross, Jennifer L Best, Leonard I Zon, Grace.
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Volume 128, Issue 7, Pages (June 2005)
Volume 57, Issue 2, Pages (October 2000)
Tom Misteli, David L Spector  Molecular Cell 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer 
SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor
A Smad Transcriptional Corepressor
Volume 20, Issue 6, Pages (December 2005)
Coupling of Transcription with Alternative Splicing
Presentation transcript:

Volume 129, Issue 4, Pages 1225-1236 (October 2005) β-Catenin Interacts With the FUS Proto-oncogene Product and Regulates Pre-mRNA Splicing  Satoshi Sato, Masashi Idogawa, Kazufumi Honda, Gen Fujii, Hisashi Kawashima, Kouji Takekuma, Akinori Hoshika, Setsuo Hirohashi, Tesshi Yamada  Gastroenterology  Volume 129, Issue 4, Pages 1225-1236 (October 2005) DOI: 10.1053/j.gastro.2005.07.025 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Assembly of native β-catenin-containing complex in the nucleus of a colorectal cancer cell line. (A) Nuclear extract from DLD-1 cells was immunoprecipitated with anti-β-catenin mouse monoclonal antibody or control mouse IgG and analyzed by SDS-PAGE (7.5%–15%) and silver staining. The arrow (*) indicates β-catenin, and the black bars (1–12) indicate the β-catenin-interacting proteins identified by mass spectrometry: 1, TOP2A (SwissProt accession number P11388); 2, Gemin 5 (Q8TEQ6); 3, DDX9 (Q08211); 4, PARP-1 (P09874); 5, PRPU (O94906); 6, DDX1 (Q92499); 7, hnRNP M (P52272); 8, DDX5 (P17844); 9, FUS (P35637); 10, p54nrb (Q15233); 11, hnRNP G (P38159); and 12, hnRNP A2/B1 (P22626). (B) Nuclear extract from DLD-1 cells was immunoprecipitated with anti-β-catenin mouse monoclonal antibody or control mouse IgG. The immunoprecipitates were blotted with anti-β-catenin, anti-FUS, anti-p54nrb, anti-DDX5, anti-TOP2A, anti-hnRNP A1, anti-hnRNP K, and anti-hnRNP A2/B1 antibodies. Note that FUS appears as double bands. These bands probably reflect posttranslational modification because similar results were obtained by transfecting the cells with an HA-tagged FUS construct (Figure 3G). (C) Nuclear extract from DLD-1 cells was immunoprecipitated with anti-FUS rabbit polyclonal antibody, control rabbit IgG, anti-TCF-4 mouse monoclonal antibody, and control mouse IgG. The immunoprecipitates were blotted with anti-β-catenin, anti-FUS, and anti-TCF-3/4 antibodies. Gastroenterology 2005 129, 1225-1236DOI: (10.1053/j.gastro.2005.07.025) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Two-hybrid analysis of the interaction between FUS and β-catenin proteins. (A) Two-hybrid analysis of the interaction between the full-length FUS protein (amino acids 1–526) and deletion mutants of β-catenin. HEK 293 cells were cotransfected with pACT carrying the entire coding sequence of FUS cDNA (pACT-FUS, black bars) or empty pACT (pACT-control, gray bars) and pBIND carrying a cDNA construct (NM_001904) encoding the indicated amino acid sequence of the β-catenin protein or empty pBIND (Control). The luciferase activity was normalized to that of the control transfectant (pACT-control and pBIND control) and expressed as the fold increase. Bars, SD. (B) Two-hybrid analysis of the interaction between the N-terminal 249 amino acids of β-catenin and deletion mutants of FUS. HEK 293 cells were cotransfected with pBIND carrying a cDNA fragment (NM_004960) encoding 1–249 amino acids of the β-catenin protein (pBIND-β-Cat, black bars) or empty pBIND (pBIND-control, gray bars) and pACT carrying a cDNA fragment encoding the indicated amino acids of the FUS protein or empty pACT (Control). Gastroenterology 2005 129, 1225-1236DOI: (10.1053/j.gastro.2005.07.025) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Colocalization of β-catenin and FUS proteins. (A–C) Immunofluorescence microscopy of DLD-1 cells with anti-β-catenin (A, and green in C) and anti-FUS (B, and red in C) antibodies. (D–F) Immunofluorescence microscopy of HEK293 cells with anti-β-catenin (D, and green in F) and anti-FUS (E, and red in F) antibodies. (G) HEK293 cells cotransfected with pcDNA3.1-HA-FUS and pFlag-β-catenin (left) or pFlag-control (right). Twenty-four hours after transfection, the nuclear extracts were immunoprecipitated with anti-β-catenin antibody or normal mouse IgG and blotted with anti-β-catenin, anti-FUS, or anti-HA antibody. Gastroenterology 2005 129, 1225-1236DOI: (10.1053/j.gastro.2005.07.025) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 Immunohistochemistry of normal intestinal and tumor tissues from FAP and sporadic colorectal cancer patients. Expression of the FUS (A–E, G, I, J, and K) and β-catenin (F and H) proteins in the normal large intestine (A–D), adenoma (E–H), and adenocarcinoma (I–K) tissues of FAP (A–I) and sporadic colorectal cancer (J and K) patients. C and D are enlargements of the boxed areas in B. “N” (E, G, I, and J) indicates normal epithelial cells. E and F as well as G and H are from the same blocks of serial sections. Gastroenterology 2005 129, 1225-1236DOI: (10.1053/j.gastro.2005.07.025) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 5 Functional involvement of FUS in the β-catenin and TCF/LEF transcriptional complexes. (A) DLD-1 cells were cotransfected with canonical (TOP, black bars) or mutant (FOP, gray bars) TCF/LEF luciferase reporter and pcDNA3.1-HA-FUS (FUS) or an appropriate mock plasmid (Control) in triplicate. Luciferase activity was measured 24 hours after transfection. Bars, SD. (B) Colony formation of HCT-116 cells transfected with either pcDNA3.1-HA-FUS (FUS) or an appropriate mock plasmid (Control) and selected with G418 for 8 days. (C and D) Phase contrast microscopy of HCT-116 cells that were transfected with either pcDNA3.1-HA-FUS (C) or an appropriate mock plasmid (D) and selected with G418 for 8 days. Gastroenterology 2005 129, 1225-1236DOI: (10.1053/j.gastro.2005.07.025) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 6 Induction of alternative splicing by β-catenin. (A) Schematic representation of possible alternative splice variants (9S-13S and US, unspliced) produced by pCS3-MT-E1A, which carries the adenovirus E1A minigene. The anticipated sizes (bp) of the corresponding RT-PCR products are shown on the right. (B) Cos-7 cells were transiently cotransfected with 0.25 μg pCS3-MT-E1A and 1.0 μg pcDNA3.1-HA-FUS (FUS) or 0.5, 1.0, or 1.5 μg pFLAG-β-catenin as indicated at the bottom. The total amount of DNA used for the transfection was kept constant by adding empty plasmid DNA. Total RNA was extracted 48 hours after transfection and analyzed by RT-PCR. (C) Cos-7 cells were transiently cotransfected with 0.25 μg pCS3-MT-E1A as well as 1.0 μg hnRNP A1, pcDNA3.1-HA-FUS, and/or pFLAG-β-catenin as indicated at the bottom. (D and E) The relative expression levels of 10S and 9S isoforms in Figure 4B (D) and 4C (E) are expressed as the percentage of the sum of all isoforms. Gastroenterology 2005 129, 1225-1236DOI: (10.1053/j.gastro.2005.07.025) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 7 β-Catenin induces a novel splice variant of ER-β. (A) RT-PCR analysis of ER-β isoforms in HeLa cells transfected with pcDNA3.1-HA-FUS and/or pFlag-β-catenin. (B) cDNA sequence of the ER-β splice variant lacking exons 5 and 6 (Exon Δ5-6). Gastroenterology 2005 129, 1225-1236DOI: (10.1053/j.gastro.2005.07.025) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 8 Dominant-negative activity of ER-β lacking exons 5 and 6. (A) Transcriptional activity of ER-βΔ5-6. HEK293 cells were cotransfected with pFlag-CMV4 (Control), wild-type (WT) pFlag-ER-β (Exon 1-7), or pFlag-ER-βΔ5-6 (Exon Δ5-6) and pERE-TA-SEAP (ERE-TA, black bars) or pTA-SEAP (Control-TA, gray bars) reporter. The transfected cells were incubated for 48 hours in the absence (−) or presence (+) of 100 nmol/L E2 (17β-estradiol), and the amount of SEAP secreted into the culture media was measured in triplicate. Bar, SD. (B) Dominant-negative activity of ER-βΔ5-6. HEK293 cells were cotransfected with pFlag-CMV4 (−), wild-type pFlag-ER-β (WT), and/or pFlag-ER-βΔ5-6 (Δ5-6) and pERE-TA-SEAP (ERE-TA, black bars) or pTA-SEAP (Control-TA, gray bars) reporter. The transfected cells were incubated for 48 hours in the presence of 100 nmol/L of E2. (C) RT-PCR analysis of ER-α (ESR1), ER-β (ESR2), and GAPD in human colon cancer cell lines RCM-1 (a), SW48 (b), LoVo (c), LS174T (d), COLO320 (e), CCK-81 (f), HT-29 (g), SW1116 (h), HCT-8 (i), SW837 (j), HCT-116 (k), SW403 (l), COLO201 (m), LS513 (n), and SW480 (o) and breast cancer cell lines MCF-7 (p) and MDA-MB-231 (q). The asterisks indicate ER-βΔ5-6. Gastroenterology 2005 129, 1225-1236DOI: (10.1053/j.gastro.2005.07.025) Copyright © 2005 American Gastroenterological Association Terms and Conditions